Cargando…

Prostate-Specific Membrane Antigen in Anaplastic and Poorly Differentiated Thyroid Cancer—A New Diagnostic and Therapeutic Target?

SIMPLE SUMMARY: Prostate-specific membrane antigen (PSMA)-targeted therapy represents a promising therapeutic option for the treatment of advanced carcinoma, but data on the relevance of PSMA-targeted diagnostics and therapy for anaplastic (ATC) and poorly differentiated (PDTC) thyroid carcinoma are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wächter, Sabine, Di Fazio, Pietro, Maurer, Elisabeth, Manoharan, Jerena, Keber, Corinna, Pfestroff, Andreas, Librizzi, Damiano, Bartsch, Detlef K., Luster, Markus, Eilsberger, Friederike
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616254/ https://www.ncbi.nlm.nih.gov/pubmed/34830843 http://dx.doi.org/10.3390/cancers13225688

Ejemplares similares

Perioperative diagnostics of patients referred for radioiodine therapy of differentiated thyroid carcinoma: referral center experience in an iodine-insufficient country
por: Eilsberger, Friederike, et al.
Publicado: (2020)

Real-Life Performance of F-18-FDG PET/CT in Patients with Cervical Lymph Node Metastasis of Unknown Primary Tumor
por: Eilsberger, Friederike, et al.
Publicado: (2022)

Individualised Multimodal Treatment Strategies for Anaplastic and Poorly Differentiated Thyroid Cancer
por: Wächter, Sabine, et al.
Publicado: (2018)

Mutation-based, short-term “neoadjuvant” treatment allows resectability in stage IVB and C anaplastic thyroid cancer
por: Maurer, Elisabeth, et al.
Publicado: (2023)

Clinical Implications of Postoperative Hyperamylasemia after Partial Pancreaticoduodenectomy
por: Mintziras, Ioannis, et al.
Publicado: (2022)

Anti-Proliferative Effect of Radiotherapy and Implication of Immunotherapy in Anaplastic Thyroid Cancer Cells
por: Wächter, Sabine, et al.
Publicado: (2023)

Application of the American Thyroid Association Risk Assessment in Patients with Differentiated Thyroid Carcinoma in a German Population
por: Eilsberger, Friederike, et al.
Publicado: (2023)

Individualized multimodal treatment strategy for anaplastic thyroid carcinoma—Case report of long-term remission and review of literature
por: Eckhardt, S., et al.
Publicado: (2016)

Diagnostic Impact of Dual-Time PET/CT with (68)Gallium-PSMA in Prostate Cancer and (68)Gallium-DOTATOC in Neuroendocrine Tumors
por: Librizzi, Damiano, et al.
Publicado: (2023)

Selumetinib Activity in Thyroid Cancer Cells: Modulation of Sodium Iodide Symporter and Associated miRNAs
por: Wächter, Sabine, et al.
Publicado: (2018)

Epigenetic Modifications in Thyroid Cancer Cells Restore NIS and Radio-Iodine Uptake and Promote Cell Death
por: Wächter, Sabine, et al.
Publicado: (2018)

Basal cell adhesion molecule promotes metastasis‐associated processes in ovarian cancer
por: Sivakumar, Suresh, et al.
Publicado: (2023)

Pancreaticoduodenectomy Is the Best Surgical Procedure for Zollinger–Ellison Syndrome Associated with Multiple Endocrine Neoplasia Type 1
por: Kong, Weihua, et al.
Publicado: (2022)

An unusual phenotype of MEN1 syndrome with a SI-NEN associated with a deletion of the MEN1 gene
por: Manoharan, Jerena, et al.
Publicado: (2016)

Clinical Relevance of [(18)F]Florbetaben and [(18)F]FDG PET/CT Imaging on the Management of Patients with Dementia
por: Librizzi, Damiano, et al.
Publicado: (2021)

Recent Improvements in Genomic and Transcriptomic Understanding of Anaplastic and Poorly Differentiated Thyroid Cancers
por: Yoo, Seong-Keun, et al.
Publicado: (2020)

Poorly Differentiated and Anaplastic Thyroid Cancer: Insights into Genomics, Microenvironment and New Drugs
por: Prete, Alessandro, et al.
Publicado: (2021)

Second primary malignancies induced by radioactive iodine treatment of differentiated thyroid carcinoma — a critical review and evaluation of the existing evidence
por: Reinecke, Maximilian J., et al.
Publicado: (2022)

Anaplastic Thyroid Carcinoma
por: Taccaliti, Augusto, et al.
Publicado: (2012)

Development of Novel Follicular Thyroid Cancer Models Which Progress to Poorly Differentiated and Anaplastic Thyroid Cancer
por: Caperton, Caitlin O., et al.
Publicado: (2021)

BRMS1 downregulation is a poor prognostic biomarker in anaplastic thyroid carcinoma patients
por: Wu, Yu, et al.
Publicado: (2019)

Combination of Lenvatinib and Pembrolizumab Is an Effective Treatment Option for Anaplastic and Poorly Differentiated Thyroid Carcinoma
por: Dierks, Christine, et al.
Publicado: (2021)

Lenvatinib for Anaplastic Thyroid Cancer
por: Tahara, Makoto, et al.
Publicado: (2017)

Anaplastic Thyroid Carcinoma: An Update
por: Jannin, Arnaud, et al.
Publicado: (2022)

Does Contrast-Enhanced Cervical Ultrasonography Improve Preoperative Localization Results in Patients With Sporadic Primary Hyperparathyroidism?
por: Karakas, Elias, et al.
Publicado: (2012)

Molecular Pathology of Poorly Differentiated and Anaplastic Thyroid Cancer: What Do Pathologists Need to Know?
por: Volante, Marco, et al.
Publicado: (2021)

Hobnail variant of papillary thyroid carcinoma: molecular profiling and comparison to classical papillary thyroid carcinoma, poorly differentiated thyroid carcinoma and anaplastic thyroid carcinoma
por: Teng, Lianghong, et al.
Publicado: (2017)

Risk Factors for Anaplastic Thyroid Cancer
por: Zivaljevic, V., et al.
Publicado: (2014)

The Role of Tracheostomy in Anaplastic Thyroid Carcinoma
por: Xu, Jia, et al.
Publicado: (2015)

Anaplastic Thyroid Carcinoma with Gastric Metastasis
por: CHAVEZ, A.A.L., et al.
Publicado: (2018)

Treatment Outcomes in Anaplastic Thyroid Cancer
por: Corrigan, Kelsey L., et al.
Publicado: (2019)

Anaplastic Cancer of the Thyroid: The Viper in the Pit
por: Seshadri, Krishna G.
Publicado: (2019)

Genetic Alterations in Anaplastic Thyroid Carcinoma
por: Rashid, M., et al.
Publicado: (2019)

Poorly differentiated and anaplastic thyroid carcinomas: chromosomal and oligo-array profile of five new cell lines
por: Rodrigues, R F, et al.
Publicado: (2007)

The neutrophil to lymphocyte ratio can discriminate anaplastic thyroid cancer against poorly or well differentiated cancer
por: Cho, Jin-Seong, et al.
Publicado: (2015)

Clinical, pathological and genetic features of anaplastic and poorly differentiated thyroid cancer: A single institute experience
por: Romei, Cristina, et al.
Publicado: (2018)

FGF-Receptors and PD-L1 in Anaplastic and Poorly Differentiated Thyroid Cancer: Evaluation of the Preclinical Rationale
por: Adam, Pia, et al.
Publicado: (2021)

DNA damage and repair in peripheral blood mononuclear cells after internal ex vivo irradiation of patient blood with (131)I
por: Schumann, S., et al.
Publicado: (2021)

The mutation profile of differentiated thyroid cancer coexisting with undifferentiated anaplastic cancer resembles that of anaplastic thyroid cancer but not that of archetypal differentiated thyroid cancer
por: Mika, Justyna, et al.
Publicado: (2020)

Frequency and Prognostic Significance of Intertumoural Heterogeneity in Multifocal Jejunoileal Neuroendocrine Tumours
por: Jesinghaus, Moritz, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_llle7nlnmad1vqbilm6ui4b28k